Left Atrial Appendage Management with the Watchman Device during Hybrid Ablation of Atrial Fibrillation

BACKGROUND: In the recent ESC/EACTS guidelines, left atrial appendage (LAA) occlusion or exclusion in patients undergoing (thoracoscopic) atrial fibrillation (AF) ablation surgery is recommended. The Watchman device (WD, Boston Scientific, Minnesota) has proved to reduce the risk of thromboembolic e...

Descripción completa

Detalles Bibliográficos
Autores principales: Vroomen, Mindy, Maesen, Bart, Luermans, Justin G., Crijns, Harry J., Maessen, Jos G., La Meir, Mark, Pison, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739757/
https://www.ncbi.nlm.nih.gov/pubmed/31772531
http://dx.doi.org/10.1155/2019/4525084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739757/
https://www.ncbi.nlm.nih.gov/pubmed/31772531
http://dx.doi.org/10.1155/2019/4525084

Ejemplares similares